The report highlights the global public health challenge of non-alcoholic fatty liver disease (NAFLD). It emphasizes the need for action to address this growing issue, which affects millions of people worldwide and is a leading cause of liver disease and liver-related deaths. The report also discusses the economic burden of NAFLD, including the cost of treatment and the impact on productivity. It concludes by calling for increased research and investment in prevention and treatment strategies for NAFLD.
